Skip to main content
OpenTrials

Clinical trial condition

Granulomatosis with Polyangiitis

Explore clinical trials studying Granulomatosis with Polyangiitis. Study availability and eligibility vary by location and protocol.

75 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Granulomatosis with Polyangiitis trial results

Completed

Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator

NCT05716334

Conditions
ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +19 more
Locations
  • University of Calgary Calgary, Alberta, Canada
  • University of Alberta Edmonton, Alberta, Canada
  • University of British Columbia (Vancouver Coastal Health Authority) Vancouver, British Columbia, Canada
  • St Joseph's Healthcare Hamilton (McMaster University) Hamilton, Ontario, Canada
View Trial Details
Completed

Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)

NCT02108860

Conditions
ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +15 more
Locations
  • Cedars Sinai Medical Center, Los Angeles Los Angeles, California, United States
  • University of South Florida Rheumatology Tampa, Florida, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • University of Michigan Ann Arbor, Michigan, United States
View all 20 locations
View Trial Details

Related conditions